Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose

Cancer Research

Volumn 62, Issue 10, 2002, Pages 2834-2839

  Uchimiya, Hiroshi ^a   Furukawa, Tatsuhiko ^a   Okamoto, Masahiro ^b   Nakajima, Yuichi ^a   Matsushita, Shigeto ^a   Ikeda, Ryuji ^a   Gotanda, Takenari ^a   Haraguchi, Misako ^a   Sumizawa, Tomoyuki ^a   Ono, Mayumi ^b   Kuwano, Michihiko ^b   Kanzaki, Tamotsu ^a   Akiyama, Shin Ichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXYRIBOSE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE; THYMIDINE PHOSPHORYLASE; THYMINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CHEMOTAXIS; CORNEA; ENDOTHELIUM CELL; GROWTH RATE; HYPOXIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CHEMOTAXIS; DEOXYRIBOSE; ENZYME INHIBITORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0037092979     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Angiogenic factor. Nature (Lond.)
2. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor
3. Angiogenic activity of enzymes
4. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
5. Purification and properties of an endothelial cell growth factor from human platelets
6. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase
7. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma
8. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma
9. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors
10. Suppression of metastasis by thymidine phosphorylase inhibitor
11. Thymidine phophorylase Gene mutations in MNGIE, a human mitochondrial disorder
12. Prevention of hypoxia-induced apoptosis by angiogenic factor thymidine phosphorylases
13. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation
14. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
15. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
16. Electroblotting of multiple gels: A simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose
17. The activity and expression of thymidine phosphorylase in human solid tumors
18. Induction of vascular endothelial tubular morpogenesis by human glioma cells. A model system for tumor angiogenesis
19. Involvement of interleukin-8vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor a-dependent angiogenesis
20. Novel biological function of Interleukin-4: Formation of tube-like structure by vascular endothelial cells in vitro and angiogenesis in vivo
21. Assay and purification of naturally occurring inhibitor of angiogenesis
22. The activity of soluble VCAM-I in angiogenesis stimulated by IL-4 and IL13
23. Heparin plus cortisone acetate inhibits tumor growth by blocking endothelial cell proliferation
24. Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo
25. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
26. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
27. What is the evidence that tumors are angiogenesis dependent?
28. Angiogenesis
29. Expression of thymidine phosphorylase in human gastric carcinoma
30. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma
31. Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in nonsmall cell lung cancer
32. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
33. Vascular endothelial cell growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells
34. Induction of thymidine kinase activity and clonal growth of certain leukemic cell lines by a granulocyte-derived factor
35. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine
36. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
37. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
38. Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylases mutations